Oxaliplatin in Unresectable Hepatocellular Carcinoma
NCT00280618 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL
Last updated 2009-09-15
Summary
Primary:
* To determine the Tumor Response Rate of patients with hepatocellular carcinoma treated with the combination chemotherapy of Eloxatin+5-Fluorouracil/Leucovorin
Secondary:
* Safety and tolerability of this regimen in these patients
Conditions
- Carcinoma, Hepatocellular
Interventions
- DRUG
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Pingkuan Zhang · Sanofi
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-07-31
- Primary Completion
- 2006-11-30
More Related Trials
-
Safety Study of Oxaliplatin and 5-fluorouracil Followed by FUDR for Unresectable Colorectal Liver Metastases
NCT00557557 ·Status: COMPLETED ·Phase: PHASE1
-
Combination Chemotherapy Plus Cetuximab in Treating Patients With Liver Metastases From Colorectal Cancer
NCT00056030 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver
NCT00006050 ·Status: COMPLETED ·Phase: PHASE2
-
RFA Combined With Oxaliplatin + 5-FluoroUracil/LeucoVorin (5-FU/LV) (FOLFOX4) for Recurrent HCC
NCT02426450 ·Status: UNKNOWN ·Phase: PHASE2
-
FOLFIRINOX in Patients With Inoperable Pancreatic Cancer
NCT01359007 ·Status: TERMINATED ·Phase: PHASE2
-
Leucovorin, Fluorouracil, Cetuximab, and Oxaliplatin in Treating Patients With Stage IV Colorectal Cancer and Liver Metastases That Cannot Be Removed by Surgery
NCT00544349 ·Status: COMPLETED ·Phase: PHASE2
-
Adjuvant Hepatic Arterial Infusion and Combination Chemotherapy in Treating Patients With Resectable Hepatic Metastases From Colorectal Cancer
NCT00059930 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer.
NCT00056459 ·Status: COMPLETED ·Phase: PHASE3
-
Folfox-B Study for Patients With Colorectal Liver Metastases
NCT00508872 ·Status: TERMINATED ·Phase: PHASE2
-
HAIC of Oxaliplatin, and 2400 mg/m² 5-fu vs HAIC of Oxaliplatin, and 1200 mg/m² 5-fu for Unresectable HCC: a Randomised Phase 3 Non-inferiority Trial
NCT04667351 ·Status: UNKNOWN ·Phase: PHASE3
-
Study of Erlotinib and Chemotherapy for Unresectable or Metastatic Cancer of the Esophagus and Gastric Cardia
NCT00591123 ·Status: COMPLETED ·Phase: PHASE2
-
Sorafenib + mFOLFOX for Hepatocellular Carcinoma
NCT01775501 ·Status: COMPLETED ·Phase: PHASE2
-
HAIC With FOLFOX Versus Systemic Chemotherapy With GP for Unresectable ICC
NCT04961970 ·Status: UNKNOWN ·Phase: PHASE3
-
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
NCT00069121 ·Status: COMPLETED ·Phase: PHASE3
-
Fluorouracil Plus Leucovorin With or Without Oxaliplatin in Treating Patients With Stage II or Stage III Colon Cancer
NCT00004931 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Previously Treated Metastatic Colorectal Cancer
NCT00056446 ·Status: COMPLETED ·Phase: PHASE3
-
Hepatic Artery Infusion With Oxaliplatin
NCT00244348 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Phase I/II Trial GOFL in Advanced Pancreatic Adenocarcinoma
NCT00154791 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer
NCT00003834 ·Status: COMPLETED ·Phase: PHASE2
-
Oxaliplatin and Capecitabine With or Without an Hepatic Arterial Infusion With Floxuridine in Treating Patients Who Are Undergoing Surgery and/or Ablation for Liver Metastases Due to Colorectal Cancer
NCT00268463 ·Status: TERMINATED ·Phase: PHASE3
-
Hepatic Arterial Chemotherapy With Raltitrexed and Oxaliplatin Versus Standard Chemotherapy in Unresectable Liver Metastases From Colorectal Cancer After Conventional Chemotherapy Failure
NCT01348412 ·Status: COMPLETED ·Phase: PHASE2
-
Neo-adjuvant FOLF(IRIN)OX for Resectable Pancreatic Adenocarcinoma
NCT02959879 ·Status: COMPLETED ·Phase: PHASE2
-
Hepatic Arterial Infusion With FOLFOX Alone or in Combination With IV Chemotherapy in Colon Cancer With Liver Metastasis
NCT02345746 ·Status: WITHDRAWN ·Phase: PHASE2
-
Oxaliplatin, 5-FU and Leucovorin in Combination With Oral Capecitabine for Metastatic Colorectal Cancer
NCT00205322 ·Status: COMPLETED ·Phase: PHASE2
-
Ph 1-2 Study ADI-PEG 20 Plus FOLFOX in Subjects With Advanced GI Malignancies Focusing on Hepatocellular Carcinoma
NCT02102022 ·Status: TERMINATED ·Phase: PHASE1/PHASE2